Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 28, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Essa Pharma Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 25
| |||||||
Rain Oncology Inc.
| -1.01M |
—
|
—
| -100.00% |
0
|
Jan 26
| |||||||
Essa Pharma Inc.
| 23.26K |
$5.73 | $133,274.07 | +3.06% | 784.4K |
Nov 21
| |||||||
Essa Pharma Inc.
| 76.47K |
$5.49 | $419,661.29 | +11.17% | 760.88K |
Nov 2 - Nov 3
| |||||||
Rain Oncology Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 9
| |||||||
Kezar Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 24
| |||||||
Atea Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Kezar Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Atreca, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Essa Pharma Inc.
| -272.84K |
$2.67 | -$729,051.78 | -28.50% | 684.4K |
Dec 14 - Dec 21
| |||||||
Rain Therapeutics Inc.
| 122K |
$8.10 | $987,790.00 | +13.81% | 1.01M |
Nov 21 - Nov 22
| |||||||
Atea Pharmaceuticals, Inc.
| -41.67K |
$5.15 | -$214,684.55 | -5.08% | 778.35K |
Nov 11 - Nov 14
| |||||||
Rain Therapeutics Inc.
| 42.88K |
$5.83 | $249,996.23 | +5.10% | 883.21K |
Nov 8
| |||||||
Essa Pharma Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 29
| |||||||
Rain Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Atea Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Kezar Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Atreca, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Kezar Life Sciences, Inc.
| 80K |
$16.25 | $1,299,800.00 | +9.87% | 890.69K |
Mar 18 - Mar 21
| |||||||
Rain Therapeutics Inc.
| 3.79K |
$14.30 | $54,139.80 | +0.45% | 840.33K |
Sep 21
| |||||||
Kezar Life Sciences, Inc.
| 26.69K |
$6.38 | $170,269.44 | +3.40% | 810.69K |
Sep 21 - Sep 22
| |||||||
Kezar Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 28
| |||||||
Atea Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Atreca, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Rain Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
May 14
| |||||||
Rain Therapeutics Inc.
| 836.54K |
$16.95 |
—
|
∞
| 836.54K |
Apr 23 - Apr 27
| |||||||
Rain Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Five Prime Therapeutics, Inc.
| -5.00K |
$38.00 | -$190,000.00 | -100.00% |
0
|
Apr 16
| |||||||
Essa Pharma Inc.
| 57K |
$27.00 | $1,539,000.00 | +6.33% | 957.24K |
Feb 22
| |||||||
Essa Pharma Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 11
| |||||||
Essa Pharma Inc.
| 42.21K |
$3.64 | $153,700.95 | +4.92% | 900.24K |
Dec 3 - Dec 11
| |||||||
Atea Pharmaceuticals, Inc.
| 801.27K |
$24.00 |
—
| +4,274.13% | 820.02K |
Nov 3
| |||||||
Atea Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 29
| |||||||
Atea Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Essa Pharma Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Proteostasis Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 29
| |||||||
Kezar Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 24
| |||||||
Atreca, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Kezar Life Sciences, Inc.
| 100K |
$5.50 | $550,000.00 | +14.62% | 784K |
Jun 11
| |||||||
Five Prime Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 14
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.